Atlas Trials

Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD

Clinical trial NCT02211118 · COMPLETED

Trial details

NCT number
NCT02211118
Sponsor
Dayton VA Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COPDSedationDexmedetomidine
Start date
2014-10-01
Primary completion
2015-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.